European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Are there potential increased risks of toxicities when immunotherapy and radiotherapy are combined? Current data presented at ESTROAsia24 suggest no, but sequencing and tissue microenvironment may play a role.
The impact of complex combinations of different immuno agents and RT remains unknown.”
More posts featuring ESTRO.